Stage II Endometrial Cancer Cure Rate
Endometrial cancer must be treated as early as possible. If the disease progresses to stage II, treatment efficacy becomes significantly limited. So, what is the cure rate for stage II endometrial cancer? Let’s explore this together.
Cure Rate for Stage II Endometrial Cancer
Treatment outcomes for endometrial cancer are typically evaluated using five-year survival rates—not “cure rates.” The five-year survival rate following surgery or radiotherapy is 98–100% for stages 0 to IA, 80–90% for stage IB, and approximately 70% for stage II. Prognosis strongly influences five-year survival. Generally, adenocarcinoma—common in endometrial cancer—is relatively radioresistant and has a high propensity for lymph node metastasis, resulting in a poorer prognosis compared with squamous cell carcinoma. Additionally, tumor cell differentiation correlates closely with prognosis: the higher the degree of differentiation (i.e., the more closely tumor cells resemble normal endometrial cells), the better the prognosis.

Endometrial cancer is a common gynecologic malignancy, often associated with factors such as excessive sexual activity and viral infections. Treatment strategies primarily depend on the extent and characteristics of the malignant transformation. Post-surgical management typically involves adjuvant chemotherapy or other pharmacologic interventions. Equally important is the patient’s awareness and attitude toward treatment: maintaining an optimistic, proactive mindset greatly contributes to effective disease control and timely recovery.
We hope the above information is helpful to you.